Mitochondrial complex II is a new target for anti-cancer drugs [ 2011 - 2013 ]

Research Grant

Researchers: Prof Jiri Neuzil (Principal investigator) ,  A/Pr Stephen Ralph ,  Prof Helen Blanchard

Brief description Cancer is a huge problem and is most likely to get worse. Therefore, new approaches to treatment are necessary. Cancer cells constantly mutate, so many established drugs cannot be used. A very promising approach is targeting mitochondria, the powerhouse of the cells. This is because these organelles are important for all cancer cells. We are proposing a novel way of using mitochondria as targets for a group of anti-cancer drugs that would ultimately result in efficient cancer management.

Funding Amount $AUD 448,434.84

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant